We develop proprietary drug delivery technologies and drug formulas in the field of oncology, dermatology and autoimmune diseases

News

27 October 2020

Forbes Poland about Biotts!

In latest article with @Forbespolska we’ve been discussing about our startup, investors, development plans and breakthrough MTC-Y technology. To ...

Read

01 October 2020

We are the new InCredibles – mentoring program by Sebastian Kulczyk

We are the new InCredibles! Biotts as the winner of the Startup Challenge contest, organized as part of European Economic Congress/ European Tech ...

Read

08 September 2020

We won the Start-up Challenge contest during the XII edition of the European Economic Congress!

We couldn’t miss the XII edition of the European Economic Congress in Katowice! Paweł Biernat took part in the conference, that was attended by ...

Read

22 July 2020

Polish Radio: Drugs absorbed through the skin. A breakthrough in research?

– There are several routes by which drugs can penetrate through the skin. Starting from the least used, but still having great potential: ...

Read
 

About BIOTTS

BIOTTS S.A. is a Polish biotechnological company that develops proprietary drug delivery technologies and drug formulas in the field of oncology, dermatology, and autoimmune diseases. The team of Biotts technologists has developed a proprietary technology for obtaining a universal transdermal therapeutic system: MTC-Y. Thanks to the unique properties of the system, it is possible to increase the bioavailability of active substances by several times, allowing active substances to penetrate through skin barriers up to several centimetres, reaching soft tissues and bones. The unique transdermal MTC-Y system can be easily modified to achieve a targeted action in pathologically changed tissues. By increasing the bioavailability of the substance, it is possible to reduce the therapeutic dose, while maintaining the original effect and, at the same time, reducing the side effects. The unique transdermal Biotts system enables the transport of one to several active substances, thanks to which it is possible to design multi-component drugs. Through simple modifications of the system, it is also possible to design medicines with a modified release profile for the medicinal substance.

How it works transdermal Biotts technology:

With more than thirty years of experience, the Research and Development Team is able to effectively create proprietary medicines, solve complex technological problems and create unique solutions to help people all over the world.

BIOTTS S.A. also provides research and development services for pharmaceutical, biotechnological, cosmetic and chemical companies from all over the world.

We have provided the market with a wide variety of solutions, including: a non-aggregating nanocarrier used in the production of vitamin preparations, anti-allergic drugs, semi-solid forms of a drug with a deep penetration carrier, semi-solid forms of a drug accelerating tissue reconstruction, cosmetic products with increased bioavailability based on natural resources, medicinal gels, stabilised and naturally preserved omega acids, and functional food formulas.

BIOTTS S.A.
Duńska 7 st.
54-427 Wrocław
office@biotts.com

Laboratories
Wrocław Technology Park
Omega Building
Duńska 7 street
54-424 Wrocław

Our clients

Investors

Partners